Cervical Teratoma in an Adult Man: A Case Report Including Molecular Characterization and Discussion of Malignant Potential.

Int J Surg PatholJun 9, 2026 (epub)

Hosamadean Benghashir, Mahir Petkar, Rajen Goyal

✦ AI-curated · Sources linked

Case in brief

A 36-year-old man presented with a cystic neck mass. After diagnostic evaluation, the mass was excised. Histology showed squamous epithelium, sebaceous glands, hair material, and disorganized smooth muscle bundles, supporting teratoma. FISH detected chromosome 12p gain in 24% of nuclei. Testicular ultrasound found no gonadal primary, and the findings established a primary cervical teratoma. The report discusses the lesion’s malignant potential but does not state a malignant outcome.

What made this case unusual

The adult cervical teratoma showed chromosome 12p gain in 24% of nuclei, an unusual molecular finding in this rare head and neck location.

Diagnostic / clinical pearl

In an adult with a cystic neck mass and teratomatous histology, integrate morphology with molecular testing and assess for a gonadal primary; here, testicular ultrasound was negative.

Source

Published in Int J Surg Pathol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pathology (Anatomic & Clinical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.